Two bacteria working in harmony show powerful antitumor effects. The approach could transform treatment for immunocompromised patients. A research team led by Professor Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST), working in collaboration with Daiichi Sankyo Co